NOMAD POWER SOLUTIONS, INC.
NMADNasdaq
$5.79
↑ +7.4%Jul 17 close · end-of-day
Price
1Y↑ +55.6%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$63.0M
Enterprise Value
$63.0M
P/E
—
P/S
—
P/B
7.9
EV/EBITDA
—
PEG
—
FCF Yield
—
Dividend Yield
—
Revenue (TTM)
—
Net Income (TTM)
—
Free Cash Flow (TTM)
—
Gross Margin
—
Operating Margin
—
Net Margin
—
ROE
—
ROIC
-63.5%
Debt / Equity
—
Net Cash
—
Return 1Y
+53.2%
Company profile
Lixte Biotechnology Holdings, Inc. uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agents and/or x-ray and immune checkpoint blockers; and encompasses two major categories of compounds at various stages of pre-clinical and clinical development.
- CEO
- John S. Kovach
- Sector
- Manufacturing
- Industry
- Pharmaceutical Products
- Employees
- 4
- Headquarters
- New York
- Website
- lixte.com
Management & directors
- Pursglove Geordan GarrettCEO and Chairman of the Board
- Stazzone PeterChief Financial Officer
Roles derived from SEC Form 4 filings.
Earnings
NMAD Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue——
Diluted EPS-$0.18↓ -37.9%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$3.3M | -$6.7M | -$6.3M | -$5.1M | -$3.6M | -$5.1M |
| Net income | -$3.3M | -$6.7M | -$6.3M | -$5.1M | -$3.6M | -$6.1M |
| Diluted EPS | — | — | -$3.99 | -$2.66 | -$1.59 | -$1.26 |
| Operating cash flow | -$2.1M | -$4.1M | -$4.6M | -$4.3M | -$3.2M | -$3.1M |
| Free cash flow | — | — | — | — | — | — |
| Gross margin | — | — | — | — | — | — |
| Operating margin | — | — | — | — | — | — |
| Net margin | — | — | — | — | — | — |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | -$1.0M | -$983,257.00 | -$613,497.00 | -$706,940.00 | -$774,809.00 | -$1.8M | -$1.8M | -$2.0M |
| Net income | -$1.0M | -$986,030.00 | -$617,694.00 | -$709,555.00 | -$775,673.00 | -$2.0M | -$2.6M | — |
| Diluted EPS | -$0.45 | -$0.44 | -$0.27 | -$0.29 | -$0.29 | -$0.33 | -$0.35 | -$0.18 |
| Operating cash flow | -$819,041.00 | -$957,595.00 | -$598,675.00 | -$568,483.00 | -$487,485.00 | -$926,752.00 | -$1.1M | -$1.8M |
| Free cash flow | — | — | — | — | — | — | — | — |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | — | — | — | — | — | — | — | — |
| Net margin | — | — | — | — | — | — | — | — |
Company news
Jul 15, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
No insider transactions in the last 12 months.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-01 | Stazzone Peter· Chief Financial Officer | Award | 50,000 | $0.00 | $0.00 | filing |
| 2026-07-01 | Sawyer Jason David | Award | 40,000 | $0.00 | $0.00 | filing |
| 2026-07-01 | Pursglove Geordan Garrett· CEO and Chairman of the Board | Award | 350,000 | $0.00 | $0.00 | filing |
| 2026-07-01 | Primus Guy Warren | Award | 15,000 | $0.00 | $0.00 | filing |
| 2026-07-01 | Holloway Michael Andrew | Award | 15,000 | $0.00 | $0.00 | filing |
| 2026-07-01 | Felix Lourdes | Award | 30,000 | $0.00 | $0.00 | filing |
| 2026-05-29 | Porter Stuart D | Award | 25,000 | $0.00 | $0.00 | filing |
| 2026-04-15 | Pursglove Geordan Garrett· CEO and Chairman of the Board | Award | 350,000 | — | — | filing |
| 2026-04-15 | Stazzone Peter· Chief Financial Officer | Award | 50,000 | — | — | filing |
| 2026-04-15 | Felix Lourdes | Award | 25,000 | — | — | filing |
| 2026-04-15 | Sawyer Jason David | Award | 25,000 | — | — | filing |
| 2026-04-15 | Holloway Michael Andrew | Award | 25,000 | — | — | filing |
| 2026-04-15 | Primus Guy Warren | Award | 25,000 | — | — | filing |
Latest 13 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.